55 investors have funded 10 Oncology companies head-officed in Berkeley, across 71 rounds (Apr 2011 – Nov 2025). They are ranked by how many Berkeley companies in this market they have actually backed.
"In Berkeley" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Boston, United States | SeedSeries A | 2 | 3 | 1 | Nov 2025 | 317 |
| 2 | Janus Henderson Investors | London, United Kingdom | Series DSeries C | 2 | 2 | — | Mar 2021 | 164 |
| 3 | F-Prime Capital | Cambridge, United States | Series ASeries B | 1 | 2 | — | May 2016 | 306 |
| 4 | Morningside | Series BSeries C | 1 | 2 | — | Jun 2014 | 171 | |
| 5 | Maverick Ventures | San Francisco, United States | Series BSeries C | 1 | 2 | 1 | Mar 2021 | 99 |
| 6 | Third Rock Ventures | Boston, United States | SeedSeries A | 1 | 2 | 2 | Nov 2025 | 70 |
| 7 | Novartis | Basel, Switzerland | Series ASeries B | 1 | 2 | — | May 2016 | 89 |
| 8 | Boehringer Ingelheim Venture Fund | Ingelheim am Rhein, Germany | Series A | 1 | 2 | 2 | Oct 2023 | 54 |
| 9 | Illumina Ventures | Foster City, United States | Series A | 1 | 2 | 1 | Oct 2023 | 40 |
| 10 | Sozo Ventures | Redwood City, United States | SeedSeries A | 1 | 2 | — | Nov 2025 | 43 |
| 11 | Mission Bay Capital | San Francisco, United States | Series ASeries B | 1 | 2 | — | May 2016 | 24 |
| 12 | Aliment Capital | Santa Monica, United States | Series BSeries C | 1 | 2 | 1 | Mar 2021 | 18 |
| 13 | Panacea Venture | Xuhui, China | Series A | 1 | 2 | 1 | Oct 2023 | 16 |
| 14 | Yosemite | SeedSeries A | 1 | 2 | — | Nov 2025 | 9 | |
| 15 | JLo Ventures | Series A | 1 | 2 | — | Oct 2023 | 1 | |
| 16 | Y Combinator | Mountain View, United States | Seed | 1 | 1 | 1 | Jul 2014 | 5,648 |
| 17 | Orbimed | New York City, United States | Series D | 1 | 1 | — | Jan 2015 | 422 |
| 18 | IndieBio | San Francisco, United States | Seed | 1 | 1 | 1 | Dec 2022 | 252 |
| 19 | Invus | New York City, United States | Series C | 1 | 1 | — | Mar 2021 | 174 |
| 20 | Korea Investment Holdings | Seoul, South Korea | Series A | 1 | 1 | — | Apr 2020 | 204 |
| 21 | Johnson & Johnson Innovation – JJDC | New Brunswick, United States | Series C | 1 | 1 | — | Jun 2014 | 120 |
| 22 | Pioneer Fund | San Francisco, United States | Seed | 1 | 1 | — | May 2024 | 138 |
| 23 | Pfizer | New York City, United States | Post-IPO | 1 | 1 | 1 | Jun 2023 | 110 |
| 24 | Caffeinated Capital | San Francisco, United States | Seed | 1 | 1 | — | May 2024 | 95 |
| 25 | Morningside | Newton, United States | Series B | 1 | 1 | 1 | Oct 2022 | 101 |
| 26 | S32 | Sunnyvale, United States | Series A | 1 | 1 | — | Dec 2021 | 82 |
| 27 | Adage Capital Management | Boston, United States | Series C | 1 | 1 | — | Mar 2021 | 87 |
| 28 | Farallon Capital Management | San Francisco, United States | Series C | 1 | 1 | 1 | Mar 2021 | 59 |
| 29 | AbbVie | Chicago, United States | Series C | 1 | 1 | — | Mar 2021 | 47 |
| 30 | The House Fund | Berkeley, United States | Seed | 1 | 1 | — | Feb 2018 | 52 |
| 31 | Tekla Capital Management | Boston, United States | Series C | 1 | 1 | — | Mar 2021 | 44 |
| 32 | Civilization Ventures | San Francisco, United States | Seed | 1 | 1 | — | May 2024 | 33 |
| 33 | Heritage Group | Nashville, United States | Series B | 1 | 1 | 1 | May 2016 | 35 |
| 34 | LifeSci Venture Partners | New York City, United States | Series C | 1 | 1 | — | Mar 2021 | 32 |
| 35 | Astia | San Francisco, United States | Seed | 1 | 1 | — | Dec 2014 | 29 |
| 36 | Point72 | Stamford, United States | Series C | 1 | 1 | — | Mar 2021 | 34 |
| 37 | Anterra Capital | Amsterdam, Netherlands | Series B | 1 | 1 | 1 | May 2016 | 20 |
| 38 | Berkeley Catalyst Fund | San Francisco, United States | Series B | 1 | 1 | — | Oct 2022 | 23 |
| 39 | Ridgeback Capital Management | New York City, United States | Series C | 1 | 1 | 1 | Mar 2021 | 24 |
| 40 | Avidity Partners | Dallas, United States | Series C | 1 | 1 | — | Mar 2021 | 24 |
| 41 | Genoa Ventures | San Francisco, United States | Series A | 1 | 1 | — | Mar 2015 | 19 |
| 42 | First Spark Ventures | United States | Series B | 1 | 1 | — | Oct 2022 | 18 |
| 43 | Monashee Investment Management | Boston, United States | Series C | 1 | 1 | — | Mar 2021 | 22 |
| 44 | Partner Fund Management | San Francisco | Series C | 1 | 1 | 1 | Mar 2021 | 15 |
| 45 | Avego | Alpharetta, United States | Series C | 1 | 1 | — | Mar 2021 | 14 |
| 46 | Exsight Ventures | New York City, United States | Series B | 1 | 1 | — | Oct 2022 | 11 |
| 47 | LongeVC | Lugano, Switzerland | Seed | 1 | 1 | — | May 2024 | 16 |
| 48 | freeflow | Pasadena, United States | Seed | 1 | 1 | — | May 2024 | 12 |
| 49 | Leukemia & Lymphoma Society | Rye Brook, United States | Series C | 1 | 1 | — | Mar 2021 | 9 |
| 50 | BrightEdge | Seed | 1 | 1 | — | May 2024 | 8 | |
| 51 | Heritage Medical Systems | Lancaster, United States | Series C | 1 | 1 | — | Mar 2021 | 7 |
| 52 | California Innovation Fund | Berkeley, United States | Seed | 1 | 1 | — | May 2024 | 5 |
| 53 | GKCC | Series A | 1 | 1 | — | Oct 2023 | 3 | |
| 54 | Pandect Bioventures | San Francisco, United States | Series B | 1 | 1 | — | Oct 2022 | 2 |
| 55 | Vikor Scientific | Charleston, United States | Series B | 1 | 1 | 1 | Feb 2021 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Oncology companies head-officed in Berkeley that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Caribou Biosciences cariboubio.com |
24 | 29 | $2.2B | Post-IPO Jun 2023 |
| CatenaBio catenabio.com |
7 | 7 | $16.5M | Seed May 2024 |
| Actym Therapeutics actymthera.com |
6 | 10 | $297.5M | Series A Oct 2023 |
| Valitor valitorbio.com |
6 | 6 | $140M | Series B Oct 2022 |
| Azalea Therapeutics azaleatx.com |
4 | 8 | $328M | Series A Nov 2025 |
| Aduro Biotech adurobiotech.com |
4 | 5 | $232.1M | Series D Jan 2015 |
| Nodexus nodexus.com |
3 | 3 | $61.2M | Series A Dec 2021 |
| Qantgene quantgene.com |
1 | 1 | $6M | Series B Feb 2021 |
| Laguna Bio lagunabio.com |
1 | 1 | $250K | Seed Dec 2022 |
| Bikanta bikanta.com |
1 | 1 | $120K | Seed Jul 2014 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Nov 2025 | Sozo Ventures | Azalea Therapeutics | Series A | $65M |
| Nov 2025 | Third Rock VenturesLED | Azalea Therapeutics | Series A | $65M |
| Nov 2025 | RA Capital Management | Azalea Therapeutics | Series A | $65M |
| Nov 2025 | Yosemite | Azalea Therapeutics | Series A | $65M |
| May 2024 | freeflow | CatenaBio | Seed | $2.4M |
| May 2024 | Caffeinated Capital | CatenaBio | Seed | $2.4M |
| May 2024 | LongeVC | CatenaBio | Seed | $2.4M |
| May 2024 | Pioneer Fund | CatenaBio | Seed | $2.4M |
| May 2024 | Civilization Ventures | CatenaBio | Seed | $2.4M |
| May 2024 | California Innovation Fund | CatenaBio | Seed | $2.4M |
| May 2024 | BrightEdge | CatenaBio | Seed | $2.4M |
| Oct 2023 | Boehringer Ingelheim Venture FundLED | Actym Therapeutics | Series A | $25.5M |
| Oct 2023 | Panacea Venture | Actym Therapeutics | Series A | $25.5M |
| Oct 2023 | Illumina VenturesLED | Actym Therapeutics | Series A | $25.5M |
| Oct 2023 | GKCC | Actym Therapeutics | Series A | $25.5M |
| Oct 2023 | JLo Ventures | Actym Therapeutics | Series A | $25.5M |
| Jun 2023 | PfizerLED | Caribou Biosciences | Post-IPO | $25M |
| Jan 2023 | Sozo Ventures | Azalea Therapeutics | Seed | $17M |
| Jan 2023 | Third Rock VenturesLED | Azalea Therapeutics | Seed | $17M |
| Jan 2023 | RA Capital Management | Azalea Therapeutics | Seed | $17M |
Oncology investors in other cities
Other markets in Berkeley